Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn

Granules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release capsules. The capsules are used for the short-term treatment of heartburn and other symptoms of gastroesophageal reflux disease. The approval is for capsules with strengths of 20 mg and 40 mg, and they are bioequivalent and therapeutically equivalent to the reference drug, Nexium.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news